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Patients With Left Main
Coronary Artery Vasospasm Inadvertently
Undergoing Coronary Artery Bypass Grafting Surgery
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LTo the Editor: Left main coronary artery (LMCA) vasospasm
induced by angiographic catheters during coronary angiography,
although uncommon, is a recognized complication of this proce-
dure (1,2). However, the inability to distinguish vasospasm from
obstructive disease of the LMCA can lead to inappropriate referral
for coronary artery bypass graft (CABG) surgery (2). The inci-
dence of patients with LMCA vasospasm who undergo unneces-
sary CABG is unknown. Accordingly, we sought to identify
patients with LMCA vasospasm who were falsely diagnosed with
LMCA atherothrombotic disease and then underwent CABG.
All patients who underwent CABG with angiographically
significant LMCA atherothrombotic disease (stenosis of  50%)
between January 2000 and July 2011 at Christiana Care Health
System were identified using the Society of Thoracic Surgeons
database. Among these patients, the patients who had coronary
angiography before and after CABG at our medical center were
identified using the American College of Cardiology National
Cardiovascular Registry CathPCI database. Data including age,
sex, reason for cardiac catheterization, and findings were obtained
by chart review. We relied on the official catheterization report for
stenosis severity, because not all films were still available for review.
Patients with repeat cardiac catheterization after CABG that
showed LMCA stenosis  25% were identified as cases of
probable LMCA vasospasm. In addition, cases with occlusion of
left-sided bypass grafts were also identified.
A total of 2,313 patients underwent CABG with a significant
LMCA stenosis. Of these, 385 patients had coronary angiography
Cardiac Catheterization Data Before and After CABG in Patients With InsignTable 1 Cardi c Catheterization Data B fore and After CABG in Patient
Age
(Mean 63 yrs)
Sex
(Men 62.5%)
Indication
for Initial
Angiography TVD
LMCA
Stenosis
71 M UA negative ostial
48 F angina negative ostial
75 F UA negative ostial
54 M UA negative ostial
67 F angina negative unknown
51 M UA negative distal
49 M UA positive unknown
64 M UA negative ostial
64 M angina positive mid-distal
71 M NSTEMI positive ostial
79 F AS negative ostial
79 F angina negative ostial
46 M NSTEMI positive diffuse
64 F UA negative unknown
68 M UA positive unknown
57 M UA positive diffuseAS  aortic stenosis; CABG  coronary artery bypass graft; LIMA  left internal mammary artery; LMCA
riple-vessel disease; UA  unstable angina.before and after CABG at our facility. Patients’ mean age was 63
years, and 62.5% were men. The most common indication for
initial cardiac catheterization was unstable angina (56%). The
mean interval of coronary angiography following CABG was 4.8
years. Significant LMCA stenosis was absent in 16 of 385 (4.1%)
patients on repeat cardiac catheterization after CABG. At post-
CABG cardiac catheterization, 5 of 15 (33.3%) internal mammary
conduits to the left anterior descending artery were occluded
(Table 1). Spasm was inadvertently confirmed in 1 patient who had
unstable angina, a moderately severe angiographic left main
stenosis with catheter damping, and a critically narrowed (4
mm2) lumen identified by intravascular ultrasound (IVUS). When
ubsequent angiography was believed to be normal, the previous
VUS images showed the LMCA to be critically narrow, but
bsent significant atherosclerosis in the media, which strongly
uggested spasm.
Catheter-induced vasospasm during coronary angiography has
een described (1,2), and if unrecognized or resistant to vasodila-
ors, it can be misinterpreted as LMCA atherothrombotic disease
nd referred for CABG. Edris et al. (2) reported 2 patients with
MCA vasospasm who were referred for CABG, and repeat
oronary angiography showed a normal LMCA after 6 years in the
rst patient and after just 2 days in the second patient. In a large
tudy of 7,295 retrospectively reviewed coronary angiograms,
hang et al. (3) found 30 cases of catheter-induced LMCA
asospasm (incidence, 0.41%). In their study, factors predictive of
MCA spasm were increased catheter-to-LM diameter ratio,
t LMCA Stenosis at Repeat AngiographyInsignifica t LMCA Stenosis at Repeat Angiography
CA Before CABG
an stenosis 64%)
LMCA After CABG
(Mean stenosis
5.3%)
Yrs Since CABG
(Mean 4.8)
LIMA
(Occluded
in 33.3%)
70 20 6 occluded
50 0 2 occluded
90 0 3 NA
60 0 4 patent
60 0 8 patent
40 0 6 patent
60 0 5 patent
50 0 10 occluded
70 0 1 patent
80 0 6 patent
70 0 3 patent
50 0 3 patent
65 0 6 patent
70 20 0 occluded
80 20 7 occluded
60 25 7 patentificans With
LM
(Me left main coronary artery; NSTEMI  non–ST-segment-elevation myocardial infarction; TVD 
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February 26, 2013:897–901catheter-to-LM wall contact, vessel bulging, and acute catheter-
to-LM angle.
Catheter-induced spasm must be considered in the diagnosis of
LMCA disease. However, interventional cardiologists are appro-
priately concerned about prolonging catheterization and perform-
ing additional procedures for suspected significant LMCA lesions,
given the high risks involved. Given these risks, some cardiologists’
routinely place intra-aortic balloons pumps and begin intravenous
heparin and nitroglycerin with suspected LMCA lesions. A
eading text on invasive cardiology describes significant LMCA
tenosis as a very high-risk situation and suggests a “hit and
un” technique of brief engagements with minimal contrast
njections to get enough information to proceed, yet not
eopardize patients’ safety (4). Given these reasons, the assess-
ent of LMCA stenosis remains challenging. Attempts to
meliorate possible spasm by using intracoronary nitroglycerin
eems like a reasonable routine in hemodynamically stable
atients with significant LM stenosis.
Another concern in referring these patients for CABG is
cclusion of important bypass grafts from competitive flow from
atent native LMCA, as shown in previous studies (5). In our
study, 33.3% patients had occluded internal mammary conduits
to the left anterior descending artery, likely from similar
physiology.
There were several limitations to this study. This was a
retrospective study based on chart review; we were dependent on
the catheterization report for assessment of LMCA stenosis.
There were other possibilities, besides spasm, as to how a lesion
that might be present on first, angiogram might be absent on a
subsequent angiogram; these include overcall of the pre-CABG
angiogram, an undercall of the post-CABG angiogram, develop-
ment of diffuse atherosclerosis when the original lesion was focal,
possible alteration of flow patterns that might have been altered
by the presence of grafts and differing vasomotor tone, and
angulations between the 2 studies. In addition, only a minority
of the patients who had CABG for LMCA disease had a repeat
coronary angiography at our facility; thus, we might have either
underestimated or overestimated the incidence of patients who
underwent CABG for LMCA spasm during this time. None-
theless, our findings, confirmed in 1 patient to be spasm with
IVUS and strongly suggested in the others, when added to
previous observations, suggest that LM spasm is a finite but
underdiagnosed entity, at times resulting in inappropriate
bypass surgery.
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Letter to the Editor
Lack of Activation of the
Antihypertensive Cardiac
Hormones ANP and BNP in
Human Hypertension
Macheret and colleagues (1) examined the association between
different processing variants of circulating atrial (ANP) and B-type
(BNP) natriuretic peptides and stages of hypertension in a
population-based cohort. A significant decrease in BNP/N-
terminal proBNP/N-terminal proANP was observed in partici-
pants with prehypertension; no difference was observed in hyper-
tensive participants compared with normotensive participants, and
no differences were observed for proBNP/proANP levels across all
categories of blood pressure. The authors concluded that there is a
relative deficiency of natriuretic peptides in early hypertension that
might be a target for therapeutic interventions.
A general limitation of cross-sectional analysis is that observed
associations might be the sum of overlying effects; this seems
particularly problematic with natriuretic peptides, which are in-
volved in several physiological feedback loops that are only partly
understood (2). Although the authors used multivariable modeling
(1), there might be residual confounding resulting from the strong
association of natriuretic peptide levels with metabolic traits such
as diabetes mellitus (3) and reverse causality resulting from the
activation of natriuretic peptides in myocardial hypertrophy and
coronary heart disease (4,5), both of which conditions were
associated with categories of blood pressure and the latter of which
was not adjusted for in multivariable analysis.
Macheret et al. (1) stated that “there is no definitive way to
correct for medication usage.” When acknowledging this, it is
questionable why participants with antihypertensive medication
were not excluded from the primary analysis, which would have been
the “cleanest” way to deal with this problem. Indeed, the effect of
distinct antihypertensive drugs on natriuretic peptide levels is un-
clear and different drug classes might have opposite effects on
